The library will be closed between August 10, 2026 and August 16, 2026. During this period, it will be possible to upload publications, but all other services will be suspended.
Nagy, L.,
Mezősi-Csaplár, M.,
Rebenku, I.,
Vereb, G.,
Szöőr, Á.:
Universal CAR T cells targeted to HER2 with a biotin-trastuzumab soluble linker penetrate spheroids and large tumor xenografts that are inherently resistant to trastuzumab mediated ADCC.
Front. Immunol. 15, 1-38, (article identifier: 1365172), 2024.
Sipos, F.,
Bohusné Barta, B.,
Simon, Á.,
Nagy, L.,
Dankó, T.,
Raffay, R. E.,
Petővári, G.,
Zsiros, V.,
Wichmann, B.,
Sebestyén, A.,
Műzes, G.:
Survival of HT29 Cancer Cells Is Affected by IGF1R Inhibition via Modulation of Self-DNA-Triggered TLR9 Signaling and the Autophagy Response.
Pathol. Oncol. Res. 28, 1-15, (article identifier: 1610322), 2022.
Műzes, G.,
Sebestyén, A.,
Simon, Á.,
Nagy, L.,
Barta, B.,
Danko, T.,
Kiss, A. L.,
Sipos, F. J.:
IGF1R inhibition affects the survival of HT29 cancer cells by alterations of the TLR9- and autophagy signaling.
Ann. Oncol. 30 (Suppl_5), 806-807, 2019.
Sipos, F. J.,
Nagy, L.,
Barta, B.,
Simon, Á.,
Danko, T.,
Sebestyén, A.,
Kiss, A. L.,
Műzes, G.:
Modulation of TLR9-dependent autophagy response via inhibition of c-Met signaling influences the survival of HT29 cancer cells.
Ann. Oncol. 30 (Suppl_5), v807, 2019.
